Introduction {#S1}
============

NOD-like receptors (NLRs) are cytosolic pattern recognition receptors (PRRs) that detect a variety of pathogen associated molecular patterns (PAMPs) as well as danger associated molecular patterns (DAMPs) and signal to coordinate multiple downstream pathways.^[@R1]^ When a subset of NLRs are triggered they oligomerize with an adaptor protein known as ASC (Apoptosis-associated Speck-like protein containing a CARD domain), and a pro-enzyme, caspase-1 to form a multimeric protein complex known as the inflammasome.^[@R1]^ Inflammasomes activate caspase-1, which leads to the processing and secretion of the inflammatory cytokines IL-1β and IL-18 and to a form of inflammatory cell death termed pyroptosis.^[@R2],\ [@R3]^ Recently, single nucleotide polymorphisms (SNPs) in the regulatory region of *NLRP3*, resulting in lowered expression of the inflammasome-forming NLRP3, were linked with susceptibility to Crohn's disease and this was attributed to decreased expression of IL-1β from monocytes.^[@R4]^ Moreover, several recent studies in mice reported that Nlrp3 inflammasome activation contributed to protection from chemically-induced intestinal inflammation through secretion of IL-18,^[@R5]-[@R7]^ although other investigators reported conflicting results.^[@R8]-[@R11]^

To investigate the role of the Nlrp3 inflammasome in infection-associated intestinal inflammation, we employed *Citrobacter rodentium*, an attaching and effacing (A/E) intestinal pathogen that is a model of enteropathogenic *Escherichia coli* (EPEC) infections in humans.^[@R12],\ [@R13]^ In order to colonize the intestinal mucosa, *C. rodentium* uses a type III secretion system (T3SS) to deliver effector proteins that allows attachment to epithelial cells and subversion of host signalling pathways, triggering cytoskeletal rearrangements. This results in the formation of hallmark A/E lesions on the apical epithelium, characterized by intimate bacterial attachment and effacement of the brush border microvilli ^[@R12],\ [@R13]^. How the innate immune system detects these virulent assaults to the epithelium and mounts an antimicrobial response towards *C. rodentium* is poorly characterized. In this study, we show that very early during the course of the infection, activation of Nlrp3 and Asc within non-hematopoietic cells serves to limit tissue bacterial burdens and consequently dampens intestinal inflammation.

Results {#S2}
=======

*Nlrp3^−/−^* and *Asc^−/−^* mice display exacerbated intestinal inflammation upon *C. rodentium* infection {#S3}
----------------------------------------------------------------------------------------------------------

To investigate the role of Nlrp3 inflammasome in bacterially-triggered intestinal inflammation, we infected cohorts of WT, *Nlrp3*^−/−^ and *Asc*^−/−^ mice with *Citrobacter rodentium*, a mouse intestinal pathogen that causes transient diarrhoea and intestinal inflammation.^[@R12],\ [@R13]^ It was recently reported that mice lacking a related inflammasome-forming NLR, *Nlrp6^−/−^* mice, as well as *Casp1^−/−^* and *Asc^−/−^* mice, harboured a more 'colitogenic' intestinal microbiota that exacerbated acute intestinal inflammation induced by dextran sulfate sodium (DSS) administration^[@R14]^. This 'colitogenic' flora and susceptibility phenotype could be transferred to WT mice by co-housing prior to DSS challenge^[@R14]^. Therefore, to circumvent the microbiota as a potential contributing factor to any observed differences in *Nlrp3*^−/−^ and *Asc*^−/−^ mice, these mice were co-housed with WT mice for at least 2 weeks prior to infection with *C. rodentium*. Following infection with *C. rodentium*, mice were either re-segregated by genotype, or were co-housed for the entire period of infection. We observed identical results irrespective of the overall period of co-housing.

Following oral infection with *C. rodentium* WT mice maintained their original body weight throughout the course of infection, whereas *Nlrp3*^−/−^ and *Asc*^−/−^ mice lost significant amounts of weight between day 7 and day 14 post-infection (p.i.), before returning to their original weight by day 21 ([Figure 1A](#F1){ref-type="fig"}). Interestingly *Nlrp3*^−/−^ mice lost less weight than *Asc*^−/−^ mice after infection, suggesting the involvement of other inflammasome-forming NLRs in protective immunity against *C. rodentium* or inflammasome-independent, Asc-driven functions. Overall, these results indicated that signalling through Nlrp3 and Asc protected against *C. rodentium*-induced wasting disease.

Consistent with the absence of systemic disease, *C. rodentium* infection of WT mice led only to mild intestinal inflammation with limited colonic hyperplasia, and leukocyte infiltration ([Figure 1B-D](#F1){ref-type="fig"}). In contrast, *Nlrp3*^−/−^ and *Asc*^−/−^ mice developed severe typhlitis and colitis after infection with *C. rodentium*, characterized by crypt loss, submucosal inflammation, prominent oedema, leukocyte infiltration and increased expression of inflammatory cytokines ([Figure 1B-D](#F1){ref-type="fig"} and [Figure S1](#SD1){ref-type="supplementary-material"}). Thus, activation of Nlrp3 and Asc limits *C. rodentium*-driven intestinal inflammation.

Nlrp3 and Asc activation limits *C. rodentium* colonization and systemic translocation {#S4}
--------------------------------------------------------------------------------------

To determine if the exacerbated intestinal inflammation in *Nlrp3^−/−^* and *Asc^−/−^* mice was due to an inability to control bacterial burdens we measured *C. rodentium* levels at the site of infection. Fitting with exacerbated intestinal inflammation, we observed significantly higher bacterial burdens in the caecum and distal colon of *Nlrp3*^−/−^ and *Asc*^−/−^ mice compared to WT mice, on both day 8 and day 14 p.i. ([Figure 2A and B](#F2){ref-type="fig"}). To examine whether Nlrp3 activation limited *C. rodentium* attachment to the epithelium, we visualized the infection by immunofluorescence. We observed that while *C. rodentium* was mainly localized to the luminal surface of the epithelium in WT mice, the bacterium was able to penetrate deep into the base of the crypts in *Asc^−/−^* and *Nlrp3^−/−^* mice ([Figure 2C](#F2){ref-type="fig"}). This indicated that activation of Nlrp3 and Asc limited bacterial burdens and restricted their localization within the intestine.

*C. rodentium* is thought to cause diarrhoea partly by weakening the tight junctions between epithelial cells.^[@R15]^ One potential consequence of this breach is translocation of bacteria past the intestinal barrier into systemic sites. To determine the degree of this translocation we measured the *C. rodentium* levels in the spleen. Strikingly, while we observed no translocation of *C. rodentium* in WT spleens, 80% of *Asc*^−/−^ mice and 50% of *Nlrp3*^−/−^ mice harboured detectable numbers of *C. rodentium* in their spleens at 8 days p.i. ([Figure 3A](#F3){ref-type="fig"}). In accordance with the presence of *C. rodentium* in the spleen, we also observed significant splenomegaly in *Nlrp3*^−/−^ and *Asc^−/−^* mice, but not in WT mice ([Figure 3B](#F3){ref-type="fig"}). Splenomegaly was associated with greater accumulation of granulocytes (CD11b^+^GR1^high^) in *Nlrp3*^−/−^ and *Asc^−/−^* spleens compared to WT spleens ([Figure 3C, D](#F3){ref-type="fig"}). These results indicate that signalling via Nlrp3 and Asc is important for limiting systemic translocation of *C. rodentium*, and for preventing excessive systemic inflammatory responses.

Caspase-1 activation is intact in the intestines of *C. rodentium*-infected *Nlrp3*^−/−^ mice {#S5}
---------------------------------------------------------------------------------------------

Triggering of the Nlrp3 inflammasome in leukocytes results in the activation of caspase-1 and subsequent maturation and secretion of the cytokines IL-1β, IL-1α and IL-18 ^[@R16],\ [@R17]^. However, we observed no induction of IL-1β during the course of infection, nor any differences in the relative IL-1β levels between WT and *Asc^−/−^* or *Nlrp3^−/−^* mice before or during infection ([Figure 4A](#F4){ref-type="fig"}). Similarly, levels of IL-1α were also very low and we found no difference between WT and *Asc^−/−^* or *Nlrp3^−/−^* mice ([Figure 4A](#F4){ref-type="fig"}). By contrast, we observed almost no IL-18 production by intestinal explants from *Asc*^−/−^ mice throughout the course of infection, however *Nlrp3*^−/−^ mice produced slightly higher levels of IL-18 than WT mice ([Figure 4A](#F4){ref-type="fig"}). Fitting with this pattern of IL-18 production, we found equal or greater levels of active caspase-1 (p10) and mature IL-18 in the intestines of *Nlrp3^−/−^* mice compared to WT mice at 8 days p.i., while caspase-1 p10 and mature IL-18 were barely detectable in *Asc^−/−^* mice ([Figure 4B](#F4){ref-type="fig"}). Importantly, this result suggests that the susceptibility phenotype observed in *Nlrp3^−/−^* mice may be caspase-1-independent. IL-18 has been implicated in protecting the intestinal epithelium from DSS-induced colitis,^[@R5]-[@R7]^ thus defective IL-18 production in *Asc*^−/−^ mice may explain the slightly exacerbated disease phenotype observed in *Asc^−/−^* mice relative to *Nlrp3*^−/−^ mice. However, as IL-18 production was intact in *Nlrp3*^−/−^ mice, these results indicate that the major susceptibility phenotype of *Nlrp3*^−/−^ mice to *C. rodentium* cannot be attributed to a lack of IL-18 production. Consistent with a minor role for IL-18, when we compared *Il18r1*^−/−^ and WT mice after 8 days p.i. we found only a small trend towards moderate caecal inflammation in *Il18r1*^−/−^ mice that was not statistically significant ([Figure 4C](#F4){ref-type="fig"}). However, IL-18 production did contribute to limiting bacterial burdens as *Il18r1^−/−^* mice harboured significantly higher *C. rodentium* levels in their caeca, compared to WT mice ([Figure 4D](#F4){ref-type="fig"}). Furthermore, similar to *Asc^−/−^* mice, we observed translocation of *C. rodentium* into the spleens in around 80% of *Il18r1^−/−^* mice ([Figure 4D](#F4){ref-type="fig"}). Collectively, these data suggest that IL-18 might explain the difference in disease severity between *Nlrp3^−/−^* and *Asc^−/−^* mice.

Signalling via Nlrp3 and Asc in non-hematopoietic cells limits bacterial colonization and intestinal inflammation {#S6}
-----------------------------------------------------------------------------------------------------------------

The adaptive immune system, specifically B-cell derived IgG and Th17 cells, is crucial for protection against and clearance of *C. rodentium*.^[@R18]-[@R20],\ [@R21]^ The eventual recovery of the *Nlrp3*^−/−^ and *Asc*^−/−^ mice from *C. rodentium* suggested that essential adaptive clearance mechanisms were not significantly compromised and this was confirmed by analyses of effector Th17 cell responses at late stages of infection, which were equivalent in WT, *Nlrp3*^−/−^ and *Asc*^−/−^ mice (data not shown). To confirm that susceptibility of *Nlrp3*^−/−^ and *Asc*^−/−^ mice to *C. rodentium* stemmed from an inability to mount an effective innate immune response we generated *Rag1^−/−^Nlrp3^−/−^* and *Rag1^−/−^Asc^−/−^* mice, lacking mature B and T cells, and infected them with *C. rodentium*. After 8 days p.i., we observed that *Rag1^−/−^Nlrp3^−/−^* and *Rag1^−/−^Asc^−/−^* mice still displayed significantly higher levels of intestinal inflammation compared to *Rag1^−/−^* mice, indicating that Nlrp3 and Asc confer protection against *C. rodentium* independently of the adaptive immune response ([Figure S2](#SD1){ref-type="supplementary-material"}).

To determine the cell types responsible for Nlrp3/Asc-mediated protection we generated irradiation bone marrow (BM) chimeras selectively lacking *Nlrp3* or *Asc* in distinct cellular compartments (i.e. hematopoietic or intestinal tissue cells) and infected them with *C. rodentium*. In agreement with our previous observations, control *Asc^−/−^*→*Asc*^−/−^ and *Nlrp3*^−/−^→*Nlrp3*^−/−^ BM chimeric mice displayed enhanced intestinal inflammation and weight loss compared to WT→WT mice ([Figure 5A and B](#F5){ref-type="fig"}). Selective restoration of *Nlrp3* expression in the hematopoietic compartment (WT→*Nlrp3*^−/−^) conferred no significant protection from *C. rodentium*-induced wasting disease, whereas mice with selective expression of *Nlrp3* in the non-hematopoietic compartment (*Nlrp3*^−/−^→WT) exhibited robust protection ([Figure 5A](#F5){ref-type="fig"}). Similarly, while mice in which *Asc* was selectively restored in the haematopoietic compartment (WT→*Asc*^−/−^) exhibited an intermediate phenotype, selective expression of *Asc* in the non-hematopoietic compartment (*Asc*^−/−^→WT) provided complete protection from weight loss ([Figure 5B](#F5){ref-type="fig"}). An identical disease pattern was observed for intestinal pathology; mice with selective expression of *Nlrp3* (*Nlrp3*^−/−^→WT) or *Asc* (*Asc*^−/−^→WT) in the non-hematopoietic compartment were protected from intestinal inflammation, whereas the reciprocal chimeras lacking *Nlrp3* (WT→*Nlrp3*^−/−^) or *Asc* (WT→*Asc*^−/−^) in the non-hematopoietic compartment exhibited severe intestinal inflammation ([Figure 5C and D](#F5){ref-type="fig"}). Consistent with a minor role for hematopoietic *Asc* expression, *Asc^−/−^*→WT mice had slightly more severe typhlitis than WT→WT mice, but significantly lower levels than *Asc^−/−^*→*Asc^−/−^* mice at 14 days p.i. ([Figure 5D](#F5){ref-type="fig"}).

Earlier, we observed that the exacerbated phenotype in *Asc^−/−^* and *Nlrp3^−/−^* mice was accompanied by higher bacterial burdens at the site of infection ([Figure 2A and B](#F2){ref-type="fig"}). Correspondingly, BM chimeras that selectively lacked *Nlrp3* (WT→*Nlrp3*^−/−^) or *Asc* (WT→*Asc*^−/−^) in the non-hematopoietic compartment also harboured significantly higher *C. rodentium* levels in the caecum and distal colon ([Figure 5E and F](#F5){ref-type="fig"}), although there again appeared to be a minor role for *Asc* in hematopoietic cells ([Figure 5F](#F5){ref-type="fig"}). To determine whether Nlrp3 or Asc-mediated protection correlated with caspase-1 activation we assessed caspase-1 cleavage. Intriguingly, caspase-1 activation (p10) was absent in the caeca of mice lacking Asc in non-haematopoietic cells (WT→*Asc*^−/−^) ([Figure 5G](#F5){ref-type="fig"}), indicating that the majority of caspase-1 activation occurs in non-haematopoietic cells in the gut. However, caspase-1 activation was unimpaired in all the Nlrp3 chimera groups ([Figure 5G](#F5){ref-type="fig"}), confirming our earlier conclusion that caspase-1 activation is still intact in *Nlrp3^−/−^* mice. Our earlier results suggested that Asc-dependent IL-18 production partially limited *C. rodentium* burdens in the caecum ([Figure 4D](#F4){ref-type="fig"}). To assess the cellular compartment responsible for intestinal IL-18 production we performed Western blotting in tissue samples from the BM chimeras. We observed that mature IL-18 expression in the intestine correlated strongly with Asc expression in non-haematopoietic cells as mature IL-18 expression was markedly reduced in WT→*Asc*^−/−^ BM chimeras, but remained intact in *Asc*^−/−^→WT BM chimeras ([Figure S3](#SD1){ref-type="supplementary-material"}). Consistent with a dominant protective role for non-hematopoietic Nlrp3 and Asc activation, immunofluorescence analysis indicated that Asc was strongly and ubiquitously expressed by E-cadherin^+^ IECs, whereas very few cells in the lamina propria had detectable Asc expression ([Figure 5H](#F5){ref-type="fig"}). Taken together, our findings show that activation of Nlrp3-Asc signalling in the intestinal epithelium limits *C. rodentium* colonization and confers protection against intestinal inflammation.

Nlrp3 and Asc activation mediates early control against *C. rodentium* {#S7}
----------------------------------------------------------------------

We next assessed the mechanism through which Nlrp3 and Asc activation conferred protection against *C. rodentium*. *Asc*^−/−^ and *Nlrp3*^−/−^ mice harboured higher *C. rodentium* loads compared to WT mice thus we hypothesized that impaired control of bacterial colonization might underlie the enhanced severity of intestinal inflammation in these mice. However, some enteric pathogens such as *Salmonella* gain a competitive advantage under inflammatory environments that allow them to outgrow the intestinal microbiota.^[@R22],\ [@R23]^ Thus, to determine if the outgrowth of *C. rodentium* in *Nlrp3*^−/−^ and *Asc*^−/−^ mice was the cause or the consequence of the severe intestinal inflammation, we focused on an early time point after infection. Strikingly, we found that after just 72h p.i., *Nlrp3*^−/−^ and *Asc*^−/−^ mice already harboured around 1000-fold more tissue-adherent *C. rodentium* in their caeca than WT mice ([Figure 6A](#F6){ref-type="fig"}), with clear evidence of penetration into the crypts ([Figure 6B](#F6){ref-type="fig"}), even though no intestinal pathology was detectable at this early time point ([Figure 6C, D](#F6){ref-type="fig"}). Thus, Nlrp3 and Asc activation is triggered very early in response to *C. rodentium* and functions to limit bacterial colonization and subsequent disease.

Recent studies have identified a crucial role for IL-22-producing RORγt^+^ innate lymphoid cells (ILC) in early innate immunity against *C. rodentium* ^[@R24],\ [@R25]^. IL-22 mediates protection by inducing the secretion of anti-microbial peptides (AMPs) such as RegIIIγ, by IECs ^[@R26]^. However, we observed similar frequencies of ILCs ([Figure 6E](#F6){ref-type="fig"}) and efficient induction of *Il22*, *Reg3g*, and *Il17a* in the caeca of WT, *Nlrp3*^−/−^ and *Asc*^−/−^ mice at 72h p.i. ([Figure 6F](#F6){ref-type="fig"}), as well as comparable expression of several other AMPs ([Figure S4](#SD1){ref-type="supplementary-material"}). Taken together with the bone marrow chimera results showing that the protection is mediated by non-hematopoietic cells, our data indicate that the early protection mediated by Nlrp3 and Asc activation is independent of the ILC-IL-22 axis. Furthermore, consistent with our previous findings at day 8 p.i. ([Figure 4A](#F4){ref-type="fig"}), we observed no difference in the levels of IL-1α, IL-1β, IL-18 or active caspase-1 (p10) in the intestine of WT and *Nlrp3^−/−^* mice at 72h p.i. ([Figure S5](#SD1){ref-type="supplementary-material"}), indicating that early Nlrp3 signalling in IEC protects from pathogenic infection independently of caspase-1 activation.

To further investigate the mechanism through which Nlrp3 and Asc activation promotes early protection against *C. rodentium* infection, we performed genome-wide transcriptional profiling of caecal tissue at steady state and at 72h post-infection. We found that the expression of 26 genes were increased in WT ceca at 72h p.i., however, the vast majority of these were also increased in *Nlrp3*^−/−^ and *Asc*^−/−^ ceca ([Figure S6](#SD1){ref-type="supplementary-material"}). In fact, upon infection only 5 genes were exclusively induced in WT mice but not in *Nlrp3*^−/−^ or *Asc*^−/−^ mice ([Figure S6](#SD1){ref-type="supplementary-material"}). Of these 5 genes the strongest candidate that could affect intestinal immune homeostasis was *Ccl5*, which encodes the chemokine CCL5 that has been implicated in recruitment of T cells, eosinophils and basophils into inflammatory sites.^[@R27]^ However, subsequent qPCR analyses were unable to validate the differential induction of *Ccl5* between WT and *Nlrp3*^−/−^ and *Asc*^−/−^ mice (data not shown). Somewhat surprisingly, we identified 249 genes which were induced at significantly higher levels in *Nlrp3*^−/−^ and/or *Asc*^−/−^ caeca at 72h p.i., but not in WT caeca ([Figure S6](#SD1){ref-type="supplementary-material"}). Approximately 50% (124) of these genes were increased in both *Nlrp3*^−/−^ and/or *Asc*^−/−^ mice, suggesting that this expression profile may reflect responses to the higher bacterial levels present in Nlrp3 and Asc-deficient mice at 72h p.i.. Further analyses of the caecal gene expression profiles revealed that 39 probes, encompassing 33 different genes, were expressed at significantly higher levels in WT caeca compared with *Nlrp3*^−/−^ and/or *Asc*^−/−^ caeca ([Figure S7](#SD1){ref-type="supplementary-material"}). Strikingly, the vast majority of these 33 genes were expressed at higher levels in WT mice both at steady state and at 72h p.i. ([Figure S7](#SD1){ref-type="supplementary-material"}), suggesting that baseline differences in gene expression in the intestine of WT and Nlrp3 and Asc-deficient mice might contribute to protection from *C. rodentium*.

Collectively, these data show that the major protective effect of Nlrp3 and Asc activation in the intestinal epithelium is evident very early after infection with *C. rodentium*, is not associated with caspase-1 activation and does not seem to be mediated through the production of AMPs. Transcriptional profiling revealed differentially expressed genes between WT and Nlrp3- and Asc-deficient mice that were conserved between steady state and 72h p.i.. These observations raise the possibility that factors induced by constitutive Nlrp3 and Asc activation in the intestinal epithelium during steady state conditions may limit early infection by mucosal pathogens.

Discussion {#S8}
==========

Accumulating evidence suggests that innate immune recognition at mucosal surfaces particularly within the intestine is a crucial mediator of intestinal homeostasis.^[@R28]^ Apart from basal roles at steady state, PRR signalling confers protection against a multitude of enteric pathogens.^[@R29]-[@R31]^ Much of the work however has centred on the consequences of hematopoietic cell microbial detection while non-hematopoietic cells such as IECs have been relatively understudied. As IECs are the first cells that enteric bacteria encounter they are well poised to act as sentinels to limit invasion and alert the immune system to infection.

We first showed that mice lacking *Nlrp3* exhibit exacerbated intestinal inflammation in response to infection with *C. rodentium* as compared to WT mice. This finding extends Nlrp3's previously described protective role in intestinal injury induced by chemical challenges.^[@R5],\ [@R6]^ We also observed that *Asc*^−/−^ mice exhibited an even greater disease phenotype relative to the *Nlrp3*^−/−^ mice suggesting that other NLRs utilising Asc may be involved in the protective response against *C. rodentium*.

To investigate which cellular compartment Nlrp3 and Asc activation provided protection against *C. rodentium*, we created irradiation bone marrow chimeras, which revealed a major protective role for Nlrp3 and Asc activation in non-hematopoietic cells. Furthermore, using immunofluorescence microscopy, we observed that IECs ubiquitously expressed high levels of Asc, whereas very few cells in the lamina propria had detectable Asc, suggesting that IECs are the major cell type in which this protective Nlrp3 and Asc activation is occurring. *C. rodentium* colonizes the intestine by intimate attachment to IECs via a T3SS which delivers numerous virulence factors to the host.^[@R13]^ Collectively these virulence factors enable *C. rodentium* to disrupt host processes, such as actin polymerization, water reabsorption and epithelial tight junction maintenance, ultimately leading to intestinal inflammation and diarrhoea.^[@R15]^ As IECs are the first cells to come into contact with *C. rodentium* they are ideally positioned to detect *C. rodentium* and the outcomes of these virulent assaults. Consistent with this hypothesis others have reported that MyD88 and NOD2 signalling within the non-hematopoietic compartment is important for optimal protection against *C. rodentium* infection.^[@R31]-[@R33]^ Our findings reinforce the concept that innate immune recognition at the epithelial barrier has a crucial function in the initiation of protective immunity^[@R34]^ and extend this paradigm to include activation of NLRs in IECs.

We next ascertained the mechanism through which Nlrp3-Asc activation conferred protection. As *Asc^−/−^* and *Nlrp3^−/−^* mice consistently harboured higher *C. rodentium* burdens than WT mice, we asked whether this could explain the exacerbated phenotype. Since some enteric pathogens such as *S. typhimurium* gain a selective advantage under inflammatory conditions,^[@R22],\ [@R23]^ we could not be certain that higher *C. rodentium* levels were not merely a consequence of greater inflammation levels in *Asc^−/−^* and *Nlrp3^−/−^* mice. We thus measured the levels of *C. rodentium* in the tissue after 72h of infection, before the onset of intestinal inflammation, and found that *Nlrp3^−/−^* and *Asc^−/−^* mice already harboured \~1000-fold more tissue-adherent bacteria. Together, our findings show that signalling via Nlrp3 and Asc in non-hematopoietic cells early during the course of infection limits *C. rodentium* levels in the caecum and consequently dampens the ensuing intestinal inflammation.

Sensing of an infection at the epithelial barrier can have two foreseeable outcomes. First, activation of an effector antimicrobial response could directly limit the invading pathogen, such as the production of antimicrobial peptides. Second, recruitment and/or conditioning of other cells that subsequently clear the pathogen, for example Nod2 sensing in stromal cells triggers the production of Ccl2, attracting inflammatory monocytes which promote *C. rodentium* clearance.^[@R31]^ The first outcome would be predicted to be engaged with rapid kinetics early on in the response while the second outcome might take relatively longer. Our result showing higher pathogen burdens after 72h in *Nlrp3*^−/−^ and *Asc^−/−^* mice coupled with the non-hematopoietic phenotype, suggests that an epithelial-intrinsic mechanism of action limits pathogen loads early on during infection, fitting with the predicted kinetics. Indeed, others have reported that *Nlrp3^−/−^* caecal epithelial cells show a relatively impaired ability to kill *E. coli* compared to WT epithelial cells.^[@R35]^ While none of the AMPs that we measured were deficient in *Asc^−/−^* or *Nlrp3^−/−^* mice, it is conceivable that an AMP might be regulated through a post-translational modification by an effector that is downstream of Nlrp3 and Asc activation. S100 proteins for instance are leaderless peptides and have been postulated to require caspase-1 for their release^[@R36]^, however, we did not find any defect in caspase-1 activation in the intestines of *Nlrp3^−/−^* mice.

Previous studies using the DSS colitis model reported a protective effect of Nlrp3 activation in non-hematopoeitic cells and described a role for IL-18 in this protection.^[@R5],\ [@R6]^ In addition, a recent study reported that Nlrp3 and caspase-1 played a protective role during infection with *C. rodentium* and ascribed this protective effect to the production of the caspase-1-processed cytokines IL-1β and IL-18.^[@R37]^ However, this study focussed only on the latter stages of *C. rodentium* infection, from day 14 p.i. onwards, and did not identify the cell types responsible for Nlrp3-mediated protection.^[@R37]^ Our work has revealed that activation of Nlrp3 and Asc in intestinal epithelial cells acts very early in the course of infection to restrict bacterial replication and spread, which in turn limits the severity of subsequent intestinal infection. During this early phase of infection, we did not find any induction of IL-1β and we observed equivalent IL-18 production between *Nlrp3*^−/−^ and WT mice, while IL-18 production was completely abrogated in *Asc*^−/−^ mice. Consistent with this expression pattern, we found that *Nlrp3^−/−^* mice expressed equivalent levels of activated caspase-1 (p10) relative to WT mice after *C. rodentium* infection, whereas caspase-1 cleavage was greatly diminished in *Asc^−/−^* mice. The simplest explanation for these observations is that Nlrp3 activation protects against *C. rodentium*-driven disease independently of caspase-1 activation. However, it is possible that the intact caspase-1 activation observed in the absence of Nlrp3 was due to compensatory activation of alternative inflammasome-forming NLRs, although this was unable to rescue the exacerbated disease phenotype. Thus, although we cannot definitively exclude a potential role for caspase-1 in Nlrp3-mediated protection, such a hypothesis would imply that discrete, non-redundant effector pathways are triggered following caspase-1 activation by distinct inflammasomes. Furthermore, although Asc and caspase-1-dependent IL-18 production might explain the difference in disease severity between *Nlrp3^−/−^* and *Asc^−/−^* mice, it cannot account for the major susceptibility phenotype observed in *Asc^−/−^* mice compared to WT mice. This also implies that other inflammasome-forming NLRs may make a minor contribution to protection from *C. rodentium* through the production of IL-18. Consistent with a relatively minor role for IL-18 in immunity against *C. rodentium*, others have also reported that *Il18*^−/−^ mice display a mild phenotype in this model.^[@R38]^ Additionally, we observed that *Il18r1^−/−^* mice developed an intermediate phenotype after infection with *C. rodentium*; they harboured greater *C. rodentium* levels in their caeca and spleens but did not develop significantly greater intestinal inflammation compared to WT mice. Thus, the major protective effect of epithelial Nlrp3 activation appears to be independent of caspase-1. This finding has important implications for our understanding of NLR activation in distinct cell types, as it suggests that the Nlrp3-Asc signalling circuits that have been elucidated through studies in hematopoietic cells may not be similarly hard-wired in other cell types. When taken together with the findings of Liu *et al*^[@R37]^, our results suggest that there may be two phases of Nlrp3/Asc activation that contribute to protection from *C. rodentium*; the very early IEC-intrinsic innate pathway described in our study; and a later circuit, most likely in myeloid cells, leading to classical caspase-1 inflammasome activation and the secretion of IL-1β and IL-18 ^[@R37]^. Evidence of the important contribution of the latter pathway is provided by the reported susceptibility phenotypes of *Casp1*^−/−^ and *Il1r^−/−^* after infection with *C. rodentium*.^[@R37],\ [@R38]^

The effector pathways triggered following Nlrp3 activation in non haematopoietic cells have not been well studied, but additional proteins linked to NLR activation, such as HMGB1 released by means of unconventional protein secretion, might also contribute to protection against *C. rodentium* and will be investigated in the future.^[@R17],\ [@R39],\ [@R40]^ Furthermore, it was recently shown the activation of the related NLR, Nlrc4, triggered caspase-1-mediated release of eicosanoids, such as leukotrienes and prostaglandins, independently of IL-1β or IL-18 secretion, highlighting that selective release of distinct classes of inflammatory mediators can occur in myeloid cells after NLR activation.^[@R41]^ Another consequence of inflammasome activation in myeloid cells is an inflammatory form of cell death known as pyroptosis.^[@R2],\ [@R3]^ An attractive hypothesis is that early Nlrp3 activation in IEC might induce pyroptosis in IEC, and this 'altruistic' cell death could limit the replicative niche for *C. rodentium*. However, we found very few numbers of TUNEL^+^ IECs in the intestines of *Nlrp3^−/−^*, *Asc^−/−^* and WT mice after infection with *C. rodentium* (data not shown). Furthermore, mice lacking caspase-11, a key upstream mediator of pyroptosis, displayed similar susceptibility to *C. rodentium* infection compared to WT mice.^[@R42]^ Thus, the potential role of pyroptosis in protection against *C. rodentium* infection remains to be resolved.

An open question remains as to how precisely *C. rodentium* triggers Nlrp3 and Asc activation. Several studies have shown that *C. rodentium*, upon injection of effector proteins into epithelial cells, destabilize host cell mitochondria and cause apoptosis.^[@R15]^ Recent studies of the mechanism of Nlrp3 activation have uncovered a role for mitochondrial dysfunction in the triggering of inflammasome activation,^[@R43],\ [@R44]^ suggesting that T3SS delivered effector proteins could potentiate Nlrp3 activation within IECs. In contrast, a recent study showed that the *C. rodentium* T3SS was dispensable for activating the inflammasome in bone marrow-derived macrophages *in vitro*.^[@R37]^ Future work will address this question using a panel of virulence factor-deficient *C. rodentium* mutants *in vivo.*

Overall our study has identified an early protective circuit in the intestinal epithelium driven by signalling though Nlrp3 and Asc that provides protection against bacterial-driven intestinal inflammation. This may constitute a key function through which Nlrp3 and Asc help maintain intestinal homeostasis and could represent the dysregulated pathway in Crohn's disease patients with SNPs in *NLRP3*.

Methods {#S9}
=======

Ethics statement {#S10}
----------------

Animal experiments were conducted in accordance with the UK Scientific Procedures Act of 1986 under a Project License authorized by the UK Home Office Animal Procedures Committee and approved by the Sir William Dunn School of Pathology Local Ethical Review Committee.

Mice {#S11}
----

WT C57BL/6 (B6), 129SvEv, B6.*Asc*^−/−^, B6.*Il18r1^−/−^* (Jackson, USA) and B6.*Nlrp3*^−/−^ mice were bred and maintained under specific pathogen-free conditions in accredited animal facilities at the University of Oxford, UK. Mice were older than 6 weeks of ages when used and aged and sex-matched. Experimental cohorts were co-housed for at least 2 weeks prior to infection with *C. rodentium*. During *C. rodentium* infection experiments, WT, *Nlrp3^−/−^* and *Asc^−/−^* cohorts were either co-housed throughout the entire infection period, or were re-segregated into their respective genotypes and housed separately after infection. We obtained similar results irrespective of whether co-housing was maintained or discontinued after infection with *C. rodentium*.

Quantitative PCR {#S12}
----------------

Total RNA was isolated using Qiagen RNeasy Mini Kit. RNA was reverse transcribed using Superscript III reverse transcriptase (Invitrogen) and oligo-dT primers. Gene expression was assessed using primer and probes from Applied Biosystems TaqMan® Gene Expression Assay on a Chromo4 detection system (MJ Research). Expression levels were normalized to *Hprt1* and calculations were made using the 2^−ΔCt^ method.^[@R45]^

Bacterial infection {#S13}
-------------------

A single *C. rodentium* colony was transferred to nalidixic acid-supplemented LB broth and grown overnight to saturation. The next day, the culture was diluted to an optical density of 0.05 and grown to log phase before harvest by centrifugation and resuspension in PBS. Mice were orally gavaged with 200μl of PBS containing \~10^9^ *C. rodentium* (nalidixic acid resistant) (ICC169). Following infection, mice were weighed every day and culled if weight loss exceeded 20% of starting weight.

Colony counts of *C. rodentium* {#S14}
-------------------------------

To measure the *C. rodentium* load in infected mice, tissues were weighed and then homogenized in 600 μl of PBS. Serial dilutions of tissue lysates were plated on nalidixic acid (Sigma; final concentration 50 μg/ml) agar plates and then incubated at 37 °C overnight before counting colonies. The number of colonies were normalised to the weight of the tissue (CFU/g).

Total protein extracts and immunoblot analysis {#S15}
----------------------------------------------

Total protein extracts were prepared by homogenizing snap frozen caecal tissue in RIPA buffer containing a protease inhibitor cocktail (Roche). Protein levels were equalized by the Lowry assay (Biorad), resolved by SDS-PAGE and then analyzed with anti-caspase-1 p10 (Santa Cruz sc-514), anti-IL-18 (Abcam ab71495) anti-Tubulin (Santa Cruz sc5286). Visualization and imaging was then carried out using ECL solution (Pierce).

Irradiation bone marrow chimeras {#S16}
--------------------------------

Bone marrow was isolated from tibias and fibulas of either WT C57BL/6, *Nlrp3^−/−^*, or *Asc^−/−^* mice, and 10 × 10^6^ cells were injected intravenously into γ-irradiated 11Gy, (2 × 550rad, given 4h apart) recipient mice and left for at least 6 weeks for reconstitution.

Organ explant culture {#S17}
---------------------

To measure cytokine production, tissues were weighed, washed in antibiotic supplemented PBS and then incubated overnight in complete RPMI at 37°C. Supernatants were harvested and the levels of IL-1α, (eBioscience, San Diego, CA; 88-5019-22), IL-1β (coating antibody: eBioscience; 14-7012-85; detection antibody: eBioscience; 13-7112-85; standard: PeproTech, Rocky Hill, NJ; 211-11b), and IL-18 (eBioscience; BMS618/2TEN) measured by enzyme-linked immunosorbent assay and IFN-γ, IL-17A, IL-22, and TNFα were quantified using Flow Cytomix Cytokine Bead Assay (Bender MedSystems).^[@R46]^

Assessment of intestinal inflammation {#S18}
-------------------------------------

Mice were euthanized at the indicated time points during the course of infection whereupon tissue sections were cut and fixed in buffered 10% formalin. Sections were then cut and stained with haematoxylin and eosin (H&E). Sections of caecum and distal colon were then blinded and scored by two researchers. In summary, five categories were considered (each scored 0-3): epithelial hyperplasia/damage and goblet cell depletion; leukocyte infiltration in lamina propria; submucosal inflammation and edema; area of tissue affected; and markers of severe inflammation such as bleeding, crypt abscesses, and necrosis/ulceration. The sums of these five categories are presented in the figures (scored 0-15).

Isolation of leukocyte subpopulations and FACS {#S19}
----------------------------------------------

Cell suspensions from spleen, and the lamina propria were prepared as described previously.^[@R47]^ Cells were washed, incubated with anti-Fc receptor (anti CD16/32 from eBioscience) at 4°C. Cells were washed and stained for CD11b and Gr1, before being fixed overnight in at 4°C. Cells were washed twice and acquired with a Cyan (Dako) and analysis performed using FlowJo (Tree Star) software.

Gene expression analysis {#S20}
------------------------

Caecal RNA was extracted using the Ambion RiboPure kit (Ambion) and whole genome expression was profiled using Illumina Single Colour-Mouse WG-6_V2_0\_R0_11278593 BeadChip with direct hybridization assay. Biotinylated cRNA was prepared using the Illumina TotalPrep-96 RNA Amplification Kit (\#4393543 Ambion). Fluorescence emissions by Cy3 were imaged using iScan system (Illumina), and data was generated using the GenomaStudio 2011 software (Illumina). Data was imported to GeneSpring GX 12 (Agilent Technologies) for analysis.

Fluorescence microscopy {#S21}
-----------------------

Paraformaldehyde-fixed tissue sections were deparaffinized and antigen retrieval was performed in 0.01 M sodium citrate buffer. Slides were blocked with normal goat serum and stained with rabbit anti-*C. rodentium* antiserum^[@R48]^, and mouse anti-E-cadherin (BD Bioscience), and rabbit anti-Asc (sc 22514-R) followed by an AF555-conjugated goat-anti-rabbit and an AF488-conjugated goat-anti-mouse secondary antibody (Invitrogen). Slides were mounted in DAPI-containing Vectashield (Vector Laboratories) and then visualized using an Olympus FV1000 confocal microscope.

Statistics {#S22}
----------

Statistical significance was determined by two-way ANOVA with Bonferroni post-tests for weight curves. All other statistical significance was determined either by nonparametric Mann-Whitney test or by paired t-tests. Differences were considered statistically significant when p \< 0.05.
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![Nlrp3 and Asc activation protects against *C. rodentium*-induced wasting disease and intestinal inflammation\
WT, *Nlrp3^−/−^*, and *Asc^−/−^* mice were infected orally with \~10^9^ *C. rodentium*. Cohorts were sacrificed 8 and 14 days post-infection (p.i.) and assessed for intestinal inflammation.\
(A) Body weights of WT, *Nlrp3^−/−^*, and *Asc^−/−^* mice. Symbols denote mean weights (±SEM) as a percentage of the initial body weight (*n* = 4-16).\
(B) Representative photomicrographs depicting H&E staining of *C. rodentium* infected caeca (magnification x50).\
(C, D) Inflammation scores in the caecum (C) and distal colon (D) were assessed as described in materials and methods (*n* = 9-15).\
Data represent either a representative experiment (one of three independent experiments (A)) or pooled results from two to three independent experiments (C-D). Horizontal bars represent the median and each symbol represents an individual mouse. Statistical significance was determined by either the two-way ANOVA (A) or the Mann-Whitney test. (\* = P \< 0.05; \*\* = P \< 0.01; \*\*\* = P \< 0.001)](emss-55175-f0001){#F1}

![Activation of the Nlrp3 and Asc limits *C. rodentium* burdens\
WT, *Nlrp3^−/−^*, and *Asc^−/−^* mice were infected orally with \~10^9^ *C. rodentium*. Cohorts were sacrificed 8 and 14 days p.i.\
(A,B) *C. rodentium* burdens were measured in the caecum (A) and distal colon (B) as described in materials and methods (ND, no detectable bacteria).\
(C) Caeca from infected (8 days p.i.) WT, *Nlrp3^−/−^*, and *Asc^−/−^* mice were stained for *C. rodentium* (red), E-cadherin (green) and DAPI (blue). Bar = left panel 30μm, mid panel 15μm, right panel 70μm.\
Data represent pooled results from at least two independent experiments (A, B). Horizontal bars represent the medians and each symbol represents an individual mouse (*n* = 10). Statistical significance was determined by the Mann-Whitney test. (\* = P \< 0.05; \*\* = P \< 0.01; \*\*\* = P \< 0.001)](emss-55175-f0002){#F2}

![*C. rodentium* infected *Nlrp3^−/−^* and *Asc^−/−^* mice cannot restrict bacterial translocation and display systemic inflammation\
WT, *Nlrp3^−/−^*, and *Asc^−/−^* mice were orally infected with \~ 10^9^ *C. rodentium* and sacrificed 8 or 14 days p.i.\
(A) Splenic bacterial loads 8 days p.i.\
(B) Spleen weights\
(C) Representative FACS plots of splenic granulocytes (CD11b^+^ Gr1^hi^)\
(D) Frequency of granulocytes in the spleen (CD11b^+^ Gr1^hi^)\
Each symbol represents a single animal and data represent pooled results from at least two independent experiments (*n* = 9-20). Horizontal bars represent group medians. Statistical significance was determined by the Mann-Whitney test (\* = P \< 0.05; \*\* = P \< 0.01; \*\*\* = P \< 0.001)](emss-55175-f0003){#F3}

![Caspase-1 activation is intact in the intestines of *Nlrp3^−/−^* mice\
Cohorts of WT, *Nlrp3*^−/−^, *Il18r1^−/−^* and *Asc*^−/−^ mice were infected with \~10^9^ *C. rodentium* and sacrificed 8 days p.i.\
(A) Protein levels of IL-1β, IL-1α and IL-18 in the caecal organ explants (*n* = 4)\
(B) Immunoblot analysis of caecal protein extracts from WT, *Nlrp3^−/−^* and *Asc^−/−^* mice, probed with antibody to caspase-1, IL-18 and tubulin (*n* = 3-5)\
(C) Inflammation scores in the caecum in WT and *Il18r1^−/−^* mice (*n* = 9) and representative photomicrographs depicting hematoxylin and eosin (H&E) staining of *C. rodentium*-infected ceca.\
(D) *C. rodentium* burdens were measured in the caecum and spleen in WT and *Il18r1^−/−^* mice (*n* = 9)\
Each symbol represents a single animal and is either representative of two experiments (A, B, C) or pooled from two independent experiments (D). Bar graphs represent means (±SEM). Horizontal bars represent the median. Statistical significance was determined by the Mann-Whitney test (\* = P \< 0.05; \*\* = P \< 0.01; \*\*\* = P \< 0.001)](emss-55175-f0004){#F4}

![Nlrp3 and Asc signaling in non-hematopoietic cells provides protection from *C. rodentium* induced intestinal inflammation\
Irradiation bone marrow chimeras were generated as described in materials and methods and infected with \~10^9^ *C. rodentium* and sacrificed 8 or 14 days p.i.\
(A, B) Body weights of *Nlrp3^−/−^* (A) and *Asc^−/−^* (B) bone marrow chimeras. Symbols denote mean weights (±SEM) as a percentage of the initial body weight. Statistical significance was determined between chimera groups and controls i.e. *Asc^−/−^* → *Asc^−/−^* and *Nlrp3^−/−^* → *Nlrp3^−/−^* respectively.\
(C, D) Inflammation scores in the caecum of *Nlrp3^−/−^* (C) and *Asc^−/−^* (D) bone marrow chimeras.\
(E,F) *C. rodentium* loads in the caecum and distal colon of *Nlrp3^−/−^* (E) and *Asc^−/−^* (F) bone marrow chimeras 8 days p.i. (ND, no detectable bacteria).\
(G) Immunoblot analysis of total caecal protein extracts from WT, *Nlrp3^−/−^* and *Asc^−/−^* chimeras 8 days p.i., probed with antibody to caspase-1 and tubulin (*n* = 2-4)\
(H) Caeca from WT and *Asc^−/−^* mice were stained for Asc (red), E-cadherin (green) and DAPI (blue). Bar = 15μm.\
Data represent pooled results from two to three independent experiments, each symbol represents a single mouse with at least 6 mice per group. Horizontal bars represent the median. Statistical significance was determined by either the two-way ANOVA (A, B) or the Mann-Whitney test (C-F). (\* = P \< 0.05; \*\* = P \< 0.01; \*\*\* = P \< 0.001)](emss-55175-f0005){#F5}

![Nlrp3 and Asc activation mediates early control against *C. rodentium*\
Cohorts of WT, *Nlrp3^−/−^*, and *Asc^−/−^* mice were infected with \~10^9^ *C. rodentium* and sacrificed 72hours p.i.\
(A) *C. rodentium* loads in the caecum at 72h p.i. (*n* = 17-20)\
(B) Caecal tissues from infected mice (72h p.i.) were stained for *C. rodentium* (red), E-cadherin (green) and DAPI (blue). Bar = left panel 20μm, right panel 10μm.\
(C) Representative photomicrographs depicting H&E staining of *C. rodentium* infected caeca (magnification x50)\
(D) Inflammation scores in the caecum at 72h p.i. (n = 6-11)\
(E) Frequency of CD45^+^ Lin^−^ Thy1^+^ Sca1^+^ innate lymphoid cells (ILC) of total CD45^+^ cells in the caecum at 72h p.i. (*n* = 4)\
(F) mRNA expression levels of *Il22*, *Reg3g*, and *Il17a* at uninfected or 72h p.i. (*n* = 3)\
Data obtained from two independent experiments. Bar graphs (E and F) shown are means (±SEM). Horizontal bars (A, D) represent the medians. Statistical significance was determined by the Mann-Whitney test (\* = P \< 0.05: \*\* = P \< 0.01, \*\*\* = P \< 0.001, \*\*\*\* = P \< 0.0001)](emss-55175-f0006){#F6}
